home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

‘Pro-Ageing' Therapy for Cancer?

  April, 9 2010 9:04
your information resource in human molecular genetics

The discovery of a signalling pathway that forces cancerous cells to age could aid the development of a general approach for cancer therapy, a Nature study suggests.

Cancer cells are able to divide indefinitely without ageing. Pier Paolo Pandolfi and colleagues have identified a new pathway that drives cell senescence but only in oncogenic conditions. Loss of the gene Skp2, a key component of the pathway, profoundly restricts tumour formation in some mouse cancer models by causing cancer cells to age - in other words, it puts a stop to cell division. Furthermore, a Skp2-blocking drug is shown to induce ageing in a tissue culture cancer model.

This cancer-related ageing pathway seems not to involve most known mediators of senescence, and the fact that its effects become apparent only in cancer cells suggests that pharmacological blockade of Skp2 could prove a useful, universal approach for preventing and treating cancer.


Pier Paolo Pandolfi (Harvard Medical School, Boston, MA, USA)
E-mail: ppandolf@bidmc.harvard.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.